@the_real_mchenz @jtrebach While improved pharmacokinetics are appreciated, it's not entirely clear that new formulations result in better clinical outcomes and warrant a *century* of patent protection. For example, compare NPH insulin (1947 patent) to gl
7,441 followers
13,688 followers
288 followers
RT @Links_Medicus: Systematic review: Ultra-long‐acting insulins provide modest benefit compared to NPH insulin for Type 2 DM, resulting in…
7,381 followers
RT @Links_Medicus: Systematic review: Ultra-long‐acting insulins provide modest benefit compared to NPH insulin for Type 2 DM, resulting in…